The Biomedical Advanced Research and Development Authority in HHS’ Office of the Assistant Secretary for Preparedness and Response awarded contracts totaling approximately $39.8 million to Cook Pharmica in Bloomington, Ind., JHP Pharmaceuticals in Parsippany, N.J., DSM Pharmaceuticals in Greenville, N.C., and Nanotherapeutics in Alachua, Fla.
The companies will complete the final steps in the vaccine manufacturing process, potentially increasing national capacity to produce the flu vaccine by 20 percent, according to the news release.
HHS is also investing nearly $40 million in five burn treatments that will be developed to improve the United States’ ability to respond to a chemical, radiological, or nuclear incident, according to a news release.
More Articles on Emergency Preparedness:
HHS Provides MERS Coronavirus Guidance for Hospital Preparedness Program
Disaster Preparation 101: 3 Post-Blackout Lessons on the Anniversary of the Northeast Blackout
Patient Safety Tool: Hospital Decontamination Self-Assessment
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.